R
RGIN
vs
ALNY
ALNY
Over the past 12 months, RGIN has underperformed ALNY, delivering a return of 0% compared to the ALNY's +32% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
ALNY
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
R
|
Regenicin Inc
OTC:RGIN
|
0.0001
USD
|
|||||
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
322.15
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
RGIN, ALNY
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
R
|
Regenicin Inc
Revenue
|
|||||||||||
|
Alnylam Pharmaceuticals Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
RGIN, ALNY
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
R
|
Regenicin Inc
OTC:RGIN
|
|||||||||
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
R
|
Regenicin Inc | ||||
|
Alnylam Pharmaceuticals Inc | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
R
|
Regenicin Inc | ||||
|
Alnylam Pharmaceuticals Inc | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
RGIN, ALNY
Performance Gap
RGIN, ALNY
Performance By Year
RGIN, ALNY
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
|
Amgen Inc
NASDAQ:AMGN
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
|
| DE |
|
BioNTech SE
NASDAQ:BNTX
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
|
| US |
|
United Therapeutics Corp
NASDAQ:UTHR
|
|
| BM |
|
Roivant Sciences Ltd
NASDAQ:ROIV
|
|
| US |
|
Incyte Corp
NASDAQ:INCY
|